Sequana Medical NV (ENXTBR: SEQUA)
Health Care · Health Care Equipment & Supplies · BE
€0.61
0.00% today · -40.7% 1Y
Sequana Medical NV (ENXTBR: SEQUA) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $50.85M and employs 48 people.
Over the last twelve months the share price has lost 40.7%, trading between 0.46 and 1.09.
Tweenvest scores Sequana Medical NV across four factors: quality 6/100, value 41/100, growth 0/100. Its strongest factor is value.
SEQUA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $50.85M
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- -1.11
- Dividend yield
- —
- Beta (5Y)
- -0.29
- 52-week high
- €1.09
- 52-week low
- €0.46
- Avg volume (3M)
- —
- Shares outstanding
- 71.29M
- Employees
- 48
- Next earnings
- —
About Sequana Medical NV
Sequana Medical N.V. is a medical technology company that has reached the commercial stage, dedicated to creating innovative solutions for managing excessive fluid accumulation linked to liver conditions, malignant ascites, and heart failure. The company's key offerings include the alfapump® system, an implanted device specifically designed to treat severe and resistant liver ascites as well as malignant ascites (fluid buildup caused by cancer). Additionally, it provides Direct Sodium Removal (DSR) technology to address ongoing fluid congestion in patients with heart failure. This DSR technology is integrated into the alfapump® DSR system, a fully implantable solution for direct sodium removal therapy in heart failure patients experiencing fluid overload. Established in 2006 and headquartered in Ghent, Belgium, Sequana Medical operates across Belgium, Germany, France, Switzerland, and other international regions.
- ISIN
- BE0974340722
- Founded
- 2006
- Listed since
- Feb 11, 2019
- Exchange
- Euronext Brussels
- Currency
- EUR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.